Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Abdel-Mannan OA, Manchoon C, Rossor T, Southin JC, Tur C, Brownlee W, Byrne S, Chitre M, Coles A, Forsyth R, Kneen R, Mankad K, Ram D, West S, Wright S, Wassmer E, Lim M, Ciccarelli O, Hemingway C, Hacohen Y; UK-Childhood Inflammatory Disease Network.
Abdel-Mannan OA, et al. Among authors: forsyth r.
Neurol Neuroimmunol Neuroinflamm. 2021 May 21;8(4):e1008. doi: 10.1212/NXI.0000000000001008. Print 2021 Jul.
Neurol Neuroimmunol Neuroinflamm. 2021.
PMID: 34021056
Free PMC article.